I'm A Patient
I'm A Provider
MacuMira: Empower Your Patients with Improved Vision
Delivering a diagnosis of dry age-related macular degeneration (AMD) has long meant managing expectations rather than offering solutions. But that is changing.
With MacuMira, you finally have a solution. You can provide real help instead of just hope.
MacuMira is the first and only Health Canada-authorized therapy designed to improve visual function in patients living with dry AMD. With proven clinical outcomes and strong patient satisfaction, MacuMira gives you the ability to offer more than reassurance—you can offer results.
All MacuMira providers receive comprehensive staff training and support from the start and throughout the lifetime of their device. Learn how MacuMira works, how you can equip your clinic with this singular eye disease treatment technology, and how you can gain a new tool to support your patients.
How MacuMira Works
Training Your Team
One of our certified MacuMira trainers will visit you for a half-day of hands-on training. By the end of the day, your team will be ready to provide MacuMira treatment to patients.
Seamless Implementation
MacuMira is designed to integrate smoothly into your existing patient flow. With straightforward protocols and intuitive operation, your team can get up to speed quickly, whether or not they have experience with similar technologies.
Microcurrent Stimulation
MacuMira uses Microcurrent Stimulation to support retinal health. It’s the first and only treatment of its kind for dry AMD, built on technology that has been safely used for decades.
Patented Waveform & Delivery
MacuMira’s patented Microcurrent Stimulation was developed to maximize therapeutic efficacy. Our intuitive user interface is straightforward for a technician to operate.
Retinal Rejuvenation
MacuMira’s stimulation of RPE cells enhances mitochondrial ATP formation, leading to improved cellular function.
Maintaining Results
Patients often have noticeable improvement in visual function after the initial 10-day loading phase (4 x 32-minute sessions). These improvements can be maintained with treatment every 3 months.
Become a MacuMira Provider
There has never been a proven, noninvasive therapy for dry AMD until MacuMira. We are proud to bring this Canadian-made, globally available technology to clinics across the country.
MacuMira providers receive comprehensive training from our team to support the successful implementation of your devices. Our mission is to enhance the vision and quality of life for people worldwide living with dry AMD, and we’d appreciate your help.
By becoming a provider, you can help change the trajectory of this common, progressive eye disease. Whether you’re ready to implement MacuMira now or just gathering information, we are here to support you.
What MacuMira Providers are Saying
testeteststest
Testest
test
testtes
testtest
test
testsetse
testset
testests
test
Testest
testeset
What’s the Best Thing You Can Do To Prevent Central Vision Loss In Your Patients?
What if vision loss didn’t have to be a guarantee for patients with dry AMD? At MacuMira, we see a future where that’s possible.
For more information on implementing MacuMira, clinical data, patient education strategies, or answers to any other questions, please register using the following form.
Articles
Understanding how dry AMD affects you or your family member can make it a little easier to navigate. Learn more about this eye disease in our articles.
Your Guide to Dry Age-related Macular Degeneration: Key Treatments and Care Strategies
BlogDry age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, leading to gradual central vision loss. As the most common form of AMD, it typically develops slowly. Early detection and management are crucial for maintaining eye health. Understanding In dry AMD, the macula thins over time, often accompanied by the formation of […]
Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
BlogAge-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It comes in two forms: dry (atrophic) and wet (neovascular). While dry AMD progresses gradually over time, wet AMD can cause sudden and severe vision loss. A common question among patients and caregivers is whether wet macular degeneration can turn […]
Read More… from Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
What is geographic atrophy (GA)?
BlogHow it’s related to dry AMD and who’s the most at risk For those with dry age-related macular degeneration (dry AMD), there’s always a risk that this condition could develop into geographic atrophy (GA), a condition where retinal pigment epithelial (RPE) cells start to die off. Research estimates that there are approximately 180,000 new cases of GA […]
Your Guide to Dry Age-related Macular Degeneration: Key Treatments and Care Strategies
Dry age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, leading to gradual central vision loss. As the most common form of AMD, it typically develops slowly. Early detection and management are crucial for maintaining eye health. Understanding In dry AMD, the macula thins over time, often accompanied by the formation of […]
Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It comes in two forms: dry (atrophic) and wet (neovascular). While dry AMD progresses gradually over time, wet AMD can cause sudden and severe vision loss. A common question among patients and caregivers is whether wet macular degeneration can turn […]
Read More… from Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
What is geographic atrophy (GA)?
How it’s related to dry AMD and who’s the most at risk For those with dry age-related macular degeneration (dry AMD), there’s always a risk that this condition could develop into geographic atrophy (GA), a condition where retinal pigment epithelial (RPE) cells start to die off. Research estimates that there are approximately 180,000 new cases of GA […]
Patients
Eye Care Providers
Select your Country
Corporate:
#302, 815 – 1st Street SW
Calgary, AB
T2P 1N3
info@macumira.com
1-844-619-6263
Mailing Address:
MacuMira Medical Devices Inc
#136 1811 4th Street SW
Calgary, AB
T2S 1W2
Hours:
Mon-Fri: 8am – 5pm
Sat – Sun: Closed